Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers-Reference-Cited by-同舟云学术

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers

Published:2018-02-07 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Hutchinson James A.,Weigand Kilian,Adenugba Akinbami,Kronenberg Katharina,Haarer Jan,Zeman Florian,Riquelme Paloma,Hornung Matthias,Ahrens Norbert,Schlitt Hans J.,Geissler Edward K.,Werner Jens M.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference21 articles.

1. Therapy for hepatitis C – the costs of success;Hoofnagle;N Engl J Med,2014

2. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States;Chhatwal;Ann Intern Med,2015

3. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings;Rein;Ann Intern Med,2012

4. Diagnostics in hepatitis C: the end of response-guided therapy?;Maasoumy;J Hepatol,2016

5. New hepatitis C therapies: the toolbox, strategies, and challenges;Pawlotsky;Gastroenterology,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients’ PBMCs;Journal of Clinical and Experimental Hepatology;2023-11

2. Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals;APMIS;2023-06-25

3. Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in Guangdong, China;Journal of Medical Virology;2022-05-31

4. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients;Transplantation;2021-10

5. Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes;PLOS Pathogens;2021-08-09